Overcoming HIV drug resistance through rational drug design based on molecular, biochemical, and structural profiles of HIV resistance

Author： Yin P.   Das D.   Mitsuya H.  

Publisher： Springer Publishing Company

ISSN： 1420-682X

Source： Cellular and Molecular Life Sciences CMLS, Vol.63, Iss.15, 2006-08, pp. : 1706-1724

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

HIV Genetic Diversity and Drug Resistance

By Santos André F.   Soares Marcelo A.  

Viruses, Vol. 2, Iss. 2, 2010-02 ,pp. : 503-531

MDPI

Access to resources Recommend Favorite

Structural Aspects of Drug Resistance and Inhibition of HIV-1 Reverse Transcriptase

By Singh Kamalendra   Marchand Bruno   Kirby Karen A.   Michailidis Eleftherios   Sarafianos Stefan G.  

Viruses, Vol. 2, Iss. 2, 2010-02 ,pp. : 606-638

MDPI

Access to resources Recommend Favorite

Molecular mechanisms and design principles for promiscuous inhibitors to avoid drug resistance: Lessons learned from HIV‐1 protease inhibition

By  

PROTEINS: STRUCTURE, FUNCTION AND BIOINFORMATICS, Vol. 83, Iss. 2, 2015-02 ,pp. : 351-372

John Wiley & Sons Inc

Access to resources Recommend Favorite

Current Perspectives on HIV-1 Antiretroviral Drug Resistance

By Iyidogan Pinar   Anderson Karen S.  

Viruses, Vol. 6, Iss. 10, 2014-10 ,pp. : 4095-4139

MDPI

Access to resources Recommend Favorite

The “Connection” Between HIV Drug Resistance and RNase H

By Delviks-Frankenberry Krista A.   Nikolenko Galina N.   Pathak Vinay K.  

Viruses, Vol. 2, Iss. 7, 2010-07 ,pp. : 1476-1503

MDPI

Access to resources Recommend Favorite